Evidence map›Paper›PMID 31209152›Full record

ArticleeNeuro

Simon Trent, Jeremy Hall, William M Connelly, Adam C Errington

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Simon TrentNeuroscience and Mental Health Research Institute, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, United Kingdom.ORCID 0000-0001-9563-4281
Jeremy HallNeuroscience and Mental Health Research Institute, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, United Kingdom.
William M ConnellySchool of Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.ORCID 0000-0002-0986-6260
Adam C ErringtonNeuroscience and Mental Health Research Institute, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, United Kingdom erringtonac@cardiff.ac.uk.ORCID 0000-0002-2171-389X
Cardiff University · GBUniversity of Tasmania · AU

Funding

Medical Research Council MR/L010305/1Wellcome Trust
6 · The paper itself

Abstract

Copy number variation (CNV) at chromosomal region 15q11.2 is linked to increased risk of neurodevelopmental disorders including autism and schizophrenia. A significant gene at this locus is cytoplasmic fragile X mental retardation protein (FMRP) interacting protein 1 (

Indexed as

Inhibitory Postsynaptic PotentialsAdaptor Proteins, Signal TransducingAnimalsDentate GyrusFemaleHaploinsufficiencyInterneuronsMaleMice, Inbred C57BLParvalbuminsProtein SubunitsReceptors, GABAAdaptor Proteins, Signal TransducingCyfip1 protein, mouseParvalbuminsProtein SubunitsReceptors, GABACYFIP1dentate gyrusGABAneurodevelopmentaltonic inhibition

Identifiers

PMID31209152
PMCPMC6635810
OpenAlexW2953225697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.